Global Infectious Disease In-vitro Diagnostic Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Infectious Disease In-vitro Diagnostic Market Size 2017-2028

2.1.2 Infectious Disease In-vitro Diagnostic Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Infectious Disease In-vitro Diagnostic Segment by Type

2.2.1 Immunoassay

2.2.2 Molecular Diagnostics

2.2.3 Microbiology

2.2.4 Others

2.3 Infectious Disease In-vitro Diagnostic Market Size by Type

2.3.1 Infectious Disease In-vitro Diagnostic Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Infectious Disease In-vitro Diagnostic Market Size Market Share by Type (2017-2022)

2.4 Infectious Disease In-vitro Diagnostic Segment by Application

2.4.1 COVID-19

2.4.2 MRSA

2.4.3 Clostridium Difficile

2.4.4 Respiratory Virus

2.4.5 TB and Drug-resistant TB

2.4.6 Chlamydia

2.4.7 Gonorrhea

2.4.8 HPV

2.4.9 HIV

2.4.10 Others(Gastro-intestinal Panel Testing, Hepatitis C, Hepatitis B, etc)

2.5 Infectious Disease In-vitro Diagnostic Market Size by Application

2.5.1 Infectious Disease In-vitro Diagnostic Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Infectious Disease In-vitro Diagnostic Market Size Market Share by Application (2017-2022)

3 Infectious Disease In-vitro Diagnostic Market Size by Player

3.1 Infectious Disease In-vitro Diagnostic Market Size Market Share by Players

3.1.1 Global Infectious Disease In-vitro Diagnostic Revenue by Players (2020-2022)

3.1.2 Global Infectious Disease In-vitro Diagnostic Revenue Market Share by Players (2020-2022)

3.2 Global Infectious Disease In-vitro Diagnostic Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Infectious Disease In-vitro Diagnostic by Regions

4.1 Infectious Disease In-vitro Diagnostic Market Size by Regions (2017-2022)

4.2 Americas Infectious Disease In-vitro Diagnostic Market Size Growth (2017-2022)

4.3 APAC Infectious Disease In-vitro Diagnostic Market Size Growth (2017-2022)

4.4 Europe Infectious Disease In-vitro Diagnostic Market Size Growth (2017-2022)

4.5 Middle East & Africa Infectious Disease In-vitro Diagnostic Market Size Growth (2017-2022)

5 Americas

5.1 Americas Infectious Disease In-vitro Diagnostic Market Size by Country (2017-2022)

5.2 Americas Infectious Disease In-vitro Diagnostic Market Size by Type (2017-2022)

5.3 Americas Infectious Disease In-vitro Diagnostic Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Infectious Disease In-vitro Diagnostic Market Size by Region (2017-2022)

6.2 APAC Infectious Disease In-vitro Diagnostic Market Size by Type (2017-2022)

6.3 APAC Infectious Disease In-vitro Diagnostic Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Infectious Disease In-vitro Diagnostic by Country (2017-2022)

7.2 Europe Infectious Disease In-vitro Diagnostic Market Size by Type (2017-2022)

7.3 Europe Infectious Disease In-vitro Diagnostic Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Infectious Disease In-vitro Diagnostic by Region (2017-2022)

8.2 Middle East & Africa Infectious Disease In-vitro Diagnostic Market Size by Type (2017-2022)

8.3 Middle East & Africa Infectious Disease In-vitro Diagnostic Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Infectious Disease In-vitro Diagnostic Market Forecast

10.1 Global Infectious Disease In-vitro Diagnostic Forecast by Regions (2023-2028)

10.1.1 Global Infectious Disease In-vitro Diagnostic Forecast by Regions (2023-2028)

10.1.2 Americas Infectious Disease In-vitro Diagnostic Forecast

10.1.3 APAC Infectious Disease In-vitro Diagnostic Forecast

10.1.4 Europe Infectious Disease In-vitro Diagnostic Forecast

10.1.5 Middle East & Africa Infectious Disease In-vitro Diagnostic Forecast

10.2 Americas Infectious Disease In-vitro Diagnostic Forecast by Country (2023-2028)

10.2.1 United States Infectious Disease In-vitro Diagnostic Market Forecast

10.2.2 Canada Infectious Disease In-vitro Diagnostic Market Forecast

10.2.3 Mexico Infectious Disease In-vitro Diagnostic Market Forecast

10.2.4 Brazil Infectious Disease In-vitro Diagnostic Market Forecast

10.3 APAC Infectious Disease In-vitro Diagnostic Forecast by Region (2023-2028)

10.3.1 China Infectious Disease In-vitro Diagnostic Market Forecast

10.3.2 Japan Infectious Disease In-vitro Diagnostic Market Forecast

10.3.3 Korea Infectious Disease In-vitro Diagnostic Market Forecast

10.3.4 Southeast Asia Infectious Disease In-vitro Diagnostic Market Forecast

10.3.5 India Infectious Disease In-vitro Diagnostic Market Forecast

10.3.6 Australia Infectious Disease In-vitro Diagnostic Market Forecast

10.4 Europe Infectious Disease In-vitro Diagnostic Forecast by Country (2023-2028)

10.4.1 Germany Infectious Disease In-vitro Diagnostic Market Forecast

10.4.2 France Infectious Disease In-vitro Diagnostic Market Forecast

10.4.3 UK Infectious Disease In-vitro Diagnostic Market Forecast

10.4.4 Italy Infectious Disease In-vitro Diagnostic Market Forecast

10.4.5 Russia Infectious Disease In-vitro Diagnostic Market Forecast

10.5 Middle East & Africa Infectious Disease In-vitro Diagnostic Forecast by Region (2023-2028)

10.5.1 Egypt Infectious Disease In-vitro Diagnostic Market Forecast

10.5.2 South Africa Infectious Disease In-vitro Diagnostic Market Forecast

10.5.3 Israel Infectious Disease In-vitro Diagnostic Market Forecast

10.5.4 Turkey Infectious Disease In-vitro Diagnostic Market Forecast

10.5.5 GCC Countries Infectious Disease In-vitro Diagnostic Market Forecast

10.6 Global Infectious Disease In-vitro Diagnostic Forecast by Type (2023-2028)

10.7 Global Infectious Disease In-vitro Diagnostic Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 BD

11.1.1 BD Company Information

11.1.2 BD Infectious Disease In-vitro Diagnostic Product Offered

11.1.3 BD Infectious Disease In-vitro Diagnostic Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 BD Main Business Overview

11.1.5 BD Latest Developments

11.2 BioMérieux SA

11.2.1 BioMérieux SA Company Information

11.2.2 BioMérieux SA Infectious Disease In-vitro Diagnostic Product Offered

11.2.3 BioMérieux SA Infectious Disease In-vitro Diagnostic Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 BioMérieux SA Main Business Overview

11.2.5 BioMérieux SA Latest Developments

11.3 Abbott

11.3.1 Abbott Company Information

11.3.2 Abbott Infectious Disease In-vitro Diagnostic Product Offered

11.3.3 Abbott Infectious Disease In-vitro Diagnostic Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Abbott Main Business Overview

11.3.5 Abbott Latest Developments

11.4 Quidel Corporation

11.4.1 Quidel Corporation Company Information

11.4.2 Quidel Corporation Infectious Disease In-vitro Diagnostic Product Offered

11.4.3 Quidel Corporation Infectious Disease In-vitro Diagnostic Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Quidel Corporation Main Business Overview

11.4.5 Quidel Corporation Latest Developments

11.5 OraSure Technologies, Inc.

11.5.1 OraSure Technologies, Inc. Company Information

11.5.2 OraSure Technologies, Inc. Infectious Disease In-vitro Diagnostic Product Offered

11.5.3 OraSure Technologies, Inc. Infectious Disease In-vitro Diagnostic Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 OraSure Technologies, Inc. Main Business Overview

11.5.5 OraSure Technologies, Inc. Latest Developments

11.6 Hologic, Inc. (Gen Probe)

11.6.1 Hologic, Inc. (Gen Probe) Company Information

11.6.2 Hologic, Inc. (Gen Probe) Infectious Disease In-vitro Diagnostic Product Offered

11.6.3 Hologic, Inc. (Gen Probe) Infectious Disease In-vitro Diagnostic Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Hologic, Inc. (Gen Probe) Main Business Overview

11.6.5 Hologic, Inc. (Gen Probe) Latest Developments

11.7 Danaher

11.7.1 Danaher Company Information

11.7.2 Danaher Infectious Disease In-vitro Diagnostic Product Offered

11.7.3 Danaher Infectious Disease In-vitro Diagnostic Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Danaher Main Business Overview

11.7.5 Danaher Latest Developments

11.8 QIAGEN

11.8.1 QIAGEN Company Information

11.8.2 QIAGEN Infectious Disease In-vitro Diagnostic Product Offered

11.8.3 QIAGEN Infectious Disease In-vitro Diagnostic Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 QIAGEN Main Business Overview

11.8.5 QIAGEN Latest Developments

11.9 Roche

11.9.1 Roche Company Information

11.9.2 Roche Infectious Disease In-vitro Diagnostic Product Offered

11.9.3 Roche Infectious Disease In-vitro Diagnostic Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Roche Main Business Overview

11.9.5 Roche Latest Developments

11.10 Siemens Healthineers AG

11.10.1 Siemens Healthineers AG Company Information

11.10.2 Siemens Healthineers AG Infectious Disease In-vitro Diagnostic Product Offered

11.10.3 Siemens Healthineers AG Infectious Disease In-vitro Diagnostic Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Siemens Healthineers AG Main Business Overview

11.10.5 Siemens Healthineers AG Latest Developments

11.11 Bio-Rad Laboratories, Inc.

11.11.1 Bio-Rad Laboratories, Inc. Company Information

11.11.2 Bio-Rad Laboratories, Inc. Infectious Disease In-vitro Diagnostic Product Offered

11.11.3 Bio-Rad Laboratories, Inc. Infectious Disease In-vitro Diagnostic Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Bio-Rad Laboratories, Inc. Main Business Overview

11.11.5 Bio-Rad Laboratories, Inc. Latest Developments

12 Research Findings and Conclusion

Table 1. Infectious Disease In-vitro Diagnostic Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Immunoassay

Table 3. Major Players of Molecular Diagnostics

Table 4. Major Players of Microbiology

Table 5. Major Players of Others

Table 6. Infectious Disease In-vitro Diagnostic Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 7. Global Infectious Disease In-vitro Diagnostic Market Size by Type (2017-2022) & ($ Millions)

Table 8. Global Infectious Disease In-vitro Diagnostic Market Size Market Share by Type (2017-2022)

Table 9. Infectious Disease In-vitro Diagnostic Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 10. Global Infectious Disease In-vitro Diagnostic Market Size by Application (2017-2022) & ($ Millions)

Table 11. Global Infectious Disease In-vitro Diagnostic Market Size Market Share by Application (2017-2022)

Table 12. Global Infectious Disease In-vitro Diagnostic Revenue by Players (2020-2022) & ($ Millions)

Table 13. Global Infectious Disease In-vitro Diagnostic Revenue Market Share by Player (2020-2022)

Table 14. Infectious Disease In-vitro Diagnostic Key Players Head office and Products Offered

Table 15. Infectious Disease In-vitro Diagnostic Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 16. New Products and Potential Entrants

Table 17. Mergers & Acquisitions, Expansion

Table 18. Global Infectious Disease In-vitro Diagnostic Market Size by Regions 2017-2022 & ($ Millions)

Table 19. Global Infectious Disease In-vitro Diagnostic Market Size Market Share by Regions (2017-2022)

Table 20. Americas Infectious Disease In-vitro Diagnostic Market Size by Country (2017-2022) & ($ Millions)

Table 21. Americas Infectious Disease In-vitro Diagnostic Market Size Market Share by Country (2017-2022)

Table 22. Americas Infectious Disease In-vitro Diagnostic Market Size by Type (2017-2022) & ($ Millions)

Table 23. Americas Infectious Disease In-vitro Diagnostic Market Size Market Share by Type (2017-2022)

Table 24. Americas Infectious Disease In-vitro Diagnostic Market Size by Application (2017-2022) & ($ Millions)

Table 25. Americas Infectious Disease In-vitro Diagnostic Market Size Market Share by Application (2017-2022)

Table 26. APAC Infectious Disease In-vitro Diagnostic Market Size by Region (2017-2022) & ($ Millions)

Table 27. APAC Infectious Disease In-vitro Diagnostic Market Size Market Share by Region (2017-2022)

Table 28. APAC Infectious Disease In-vitro Diagnostic Market Size by Type (2017-2022) & ($ Millions)

Table 29. APAC Infectious Disease In-vitro Diagnostic Market Size Market Share by Type (2017-2022)

Table 30. APAC Infectious Disease In-vitro Diagnostic Market Size by Application (2017-2022) & ($ Millions)

Table 31. APAC Infectious Disease In-vitro Diagnostic Market Size Market Share by Application (2017-2022)

Table 32. Europe Infectious Disease In-vitro Diagnostic Market Size by Country (2017-2022) & ($ Millions)

Table 33. Europe Infectious Disease In-vitro Diagnostic Market Size Market Share by Country (2017-2022)

Table 34. Europe Infectious Disease In-vitro Diagnostic Market Size by Type (2017-2022) & ($ Millions)

Table 35. Europe Infectious Disease In-vitro Diagnostic Market Size Market Share by Type (2017-2022)

Table 36. Europe Infectious Disease In-vitro Diagnostic Market Size by Application (2017-2022) & ($ Millions)

Table 37. Europe Infectious Disease In-vitro Diagnostic Market Size Market Share by Application (2017-2022)

Table 38. Middle East & Africa Infectious Disease In-vitro Diagnostic Market Size by Region (2017-2022) & ($ Millions)

Table 39. Middle East & Africa Infectious Disease In-vitro Diagnostic Market Size Market Share by Region (2017-2022)

Table 40. Middle East & Africa Infectious Disease In-vitro Diagnostic Market Size by Type (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Infectious Disease In-vitro Diagnostic Market Size Market Share by Type (2017-2022)

Table 42. Middle East & Africa Infectious Disease In-vitro Diagnostic Market Size by Application (2017-2022) & ($ Millions)

Table 43. Middle East & Africa Infectious Disease In-vitro Diagnostic Market Size Market Share by Application (2017-2022)

Table 44. Key Market Drivers & Growth Opportunities of Infectious Disease In-vitro Diagnostic

Table 45. Key Market Challenges & Risks of Infectious Disease In-vitro Diagnostic

Table 46. Key Industry Trends of Infectious Disease In-vitro Diagnostic

Table 47. Global Infectious Disease In-vitro Diagnostic Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 48. Global Infectious Disease In-vitro Diagnostic Market Size Market Share Forecast by Regions (2023-2028)

Table 49. Global Infectious Disease In-vitro Diagnostic Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 50. Global Infectious Disease In-vitro Diagnostic Market Size Market Share Forecast by Type (2023-2028)

Table 51. Global Infectious Disease In-vitro Diagnostic Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 52. Global Infectious Disease In-vitro Diagnostic Market Size Market Share Forecast by Application (2023-2028)

Table 53. BD Details, Company Type, Infectious Disease In-vitro Diagnostic Area Served and Its Competitors

Table 54. BD Infectious Disease In-vitro Diagnostic Product Offered

Table 55. BD Infectious Disease In-vitro Diagnostic Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 56. BD Main Business

Table 57. BD Latest Developments

Table 58. BioMérieux SA Details, Company Type, Infectious Disease In-vitro Diagnostic Area Served and Its Competitors

Table 59. BioMérieux SA Infectious Disease In-vitro Diagnostic Product Offered

Table 60. BioMérieux SA Main Business

Table 61. BioMérieux SA Infectious Disease In-vitro Diagnostic Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 62. BioMérieux SA Latest Developments

Table 63. Abbott Details, Company Type, Infectious Disease In-vitro Diagnostic Area Served and Its Competitors

Table 64. Abbott Infectious Disease In-vitro Diagnostic Product Offered

Table 65. Abbott Main Business

Table 66. Abbott Infectious Disease In-vitro Diagnostic Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 67. Abbott Latest Developments

Table 68. Quidel Corporation Details, Company Type, Infectious Disease In-vitro Diagnostic Area Served and Its Competitors

Table 69. Quidel Corporation Infectious Disease In-vitro Diagnostic Product Offered

Table 70. Quidel Corporation Main Business

Table 71. Quidel Corporation Infectious Disease In-vitro Diagnostic Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 72. Quidel Corporation Latest Developments

Table 73. OraSure Technologies, Inc. Details, Company Type, Infectious Disease In-vitro Diagnostic Area Served and Its Competitors

Table 74. OraSure Technologies, Inc. Infectious Disease In-vitro Diagnostic Product Offered

Table 75. OraSure Technologies, Inc. Main Business

Table 76. OraSure Technologies, Inc. Infectious Disease In-vitro Diagnostic Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 77. OraSure Technologies, Inc. Latest Developments

Table 78. Hologic, Inc. (Gen Probe) Details, Company Type, Infectious Disease In-vitro Diagnostic Area Served and Its Competitors

Table 79. Hologic, Inc. (Gen Probe) Infectious Disease In-vitro Diagnostic Product Offered

Table 80. Hologic, Inc. (Gen Probe) Main Business

Table 81. Hologic, Inc. (Gen Probe) Infectious Disease In-vitro Diagnostic Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 82. Hologic, Inc. (Gen Probe) Latest Developments

Table 83. Danaher Details, Company Type, Infectious Disease In-vitro Diagnostic Area Served and Its Competitors

Table 84. Danaher Infectious Disease In-vitro Diagnostic Product Offered

Table 85. Danaher Main Business

Table 86. Danaher Infectious Disease In-vitro Diagnostic Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 87. Danaher Latest Developments

Table 88. QIAGEN Details, Company Type, Infectious Disease In-vitro Diagnostic Area Served and Its Competitors

Table 89. QIAGEN Infectious Disease In-vitro Diagnostic Product Offered

Table 90. QIAGEN Main Business

Table 91. QIAGEN Infectious Disease In-vitro Diagnostic Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 92. QIAGEN Latest Developments

Table 93. Roche Details, Company Type, Infectious Disease In-vitro Diagnostic Area Served and Its Competitors

Table 94. Roche Infectious Disease In-vitro Diagnostic Product Offered

Table 95. Roche Main Business

Table 96. Roche Infectious Disease In-vitro Diagnostic Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 97. Roche Latest Developments

Table 98. Siemens Healthineers AG Details, Company Type, Infectious Disease In-vitro Diagnostic Area Served and Its Competitors

Table 99. Siemens Healthineers AG Infectious Disease In-vitro Diagnostic Product Offered

Table 100. Siemens Healthineers AG Main Business

Table 101. Siemens Healthineers AG Infectious Disease In-vitro Diagnostic Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 102. Siemens Healthineers AG Latest Developments

Table 103. Bio-Rad Laboratories, Inc. Details, Company Type, Infectious Disease In-vitro Diagnostic Area Served and Its Competitors

Table 104. Bio-Rad Laboratories, Inc. Infectious Disease In-vitro Diagnostic Product Offered

Table 105. Bio-Rad Laboratories, Inc. Infectious Disease In-vitro Diagnostic Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 106. Bio-Rad Laboratories, Inc. Main Business

Table 107. Bio-Rad Laboratories, Inc. Latest Developments

List of Figures

Figure 1. Infectious Disease In-vitro Diagnostic Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Infectious Disease In-vitro Diagnostic Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Infectious Disease In-vitro Diagnostic Market Size Market Share by Type in 2021

Figure 7. Infectious Disease In-vitro Diagnostic in COVID-19

Figure 8. Global Infectious Disease In-vitro Diagnostic Market: COVID-19 (2017-2022) & ($ Millions)

Figure 9. Infectious Disease In-vitro Diagnostic in MRSA

Figure 10. Global Infectious Disease In-vitro Diagnostic Market: MRSA (2017-2022) & ($ Millions)

Figure 11. Infectious Disease In-vitro Diagnostic in Clostridium Difficile

Figure 12. Global Infectious Disease In-vitro Diagnostic Market: Clostridium Difficile (2017-2022) & ($ Millions)

Figure 13. Infectious Disease In-vitro Diagnostic in Respiratory Virus

Figure 14. Global Infectious Disease In-vitro Diagnostic Market: Respiratory Virus (2017-2022) & ($ Millions)

Figure 15. Infectious Disease In-vitro Diagnostic in TB and Drug-resistant TB

Figure 16. Global Infectious Disease In-vitro Diagnostic Market: TB and Drug-resistant TB (2017-2022) & ($ Millions)

Figure 17. Infectious Disease In-vitro Diagnostic in Chlamydia

Figure 18. Global Infectious Disease In-vitro Diagnostic Market: Chlamydia (2017-2022) & ($ Millions)

Figure 19. Infectious Disease In-vitro Diagnostic in Gonorrhea

Figure 20. Global Infectious Disease In-vitro Diagnostic Market: Gonorrhea (2017-2022) & ($ Millions)

Figure 21. Infectious Disease In-vitro Diagnostic in HPV

Figure 22. Global Infectious Disease In-vitro Diagnostic Market: HPV (2017-2022) & ($ Millions)

Figure 23. Infectious Disease In-vitro Diagnostic in HIV

Figure 24. Global Infectious Disease In-vitro Diagnostic Market: HIV (2017-2022) & ($ Millions)

Figure 25. Infectious Disease In-vitro Diagnostic in Others(Gastro-intestinal Panel Testing, Hepatitis C, Hepatitis B, etc)

Figure 26. Global Infectious Disease In-vitro Diagnostic Market: Others(Gastro-intestinal Panel Testing, Hepatitis C, Hepatitis B, etc) (2017-2022) & ($ Millions)

Figure 27. Global Infectious Disease In-vitro Diagnostic Market Size Market Share by Application in 2021

Figure 28. Global Infectious Disease In-vitro Diagnostic Revenue Market Share by Player in 2021

Figure 29. Global Infectious Disease In-vitro Diagnostic Market Size Market Share by Regions (2017-2022)

Figure 30. Americas Infectious Disease In-vitro Diagnostic Market Size 2017-2022 ($ Millions)

Figure 31. APAC Infectious Disease In-vitro Diagnostic Market Size 2017-2022 ($ Millions)

Figure 32. Europe Infectious Disease In-vitro Diagnostic Market Size 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Infectious Disease In-vitro Diagnostic Market Size 2017-2022 ($ Millions)

Figure 34. Americas Infectious Disease In-vitro Diagnostic Value Market Share by Country in 2021

Figure 35. Americas Infectious Disease In-vitro Diagnostic Consumption Market Share by Type in 2021

Figure 36. Americas Infectious Disease In-vitro Diagnostic Market Size Market Share by Application in 2021

Figure 37. United States Infectious Disease In-vitro Diagnostic Market Size Growth 2017-2022 ($ Millions)

Figure 38. Canada Infectious Disease In-vitro Diagnostic Market Size Growth 2017-2022 ($ Millions)

Figure 39. Mexico Infectious Disease In-vitro Diagnostic Market Size Growth 2017-2022 ($ Millions)

Figure 40. Brazil Infectious Disease In-vitro Diagnostic Market Size Growth 2017-2022 ($ Millions)

Figure 41. APAC Infectious Disease In-vitro Diagnostic Market Size Market Share by Region in 2021

Figure 42. APAC Infectious Disease In-vitro Diagnostic Market Size Market Share by Application in 2021

Figure 43. China Infectious Disease In-vitro Diagnostic Market Size Growth 2017-2022 ($ Millions)

Figure 44. Japan Infectious Disease In-vitro Diagnostic Market Size Growth 2017-2022 ($ Millions)

Figure 45. Korea Infectious Disease In-vitro Diagnostic Market Size Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Infectious Disease In-vitro Diagnostic Market Size Growth 2017-2022 ($ Millions)

Figure 47. India Infectious Disease In-vitro Diagnostic Market Size Growth 2017-2022 ($ Millions)

Figure 48. Australia Infectious Disease In-vitro Diagnostic Market Size Growth 2017-2022 ($ Millions)

Figure 49. Europe Infectious Disease In-vitro Diagnostic Market Size Market Share by Country in 2021

Figure 50. Europe Infectious Disease In-vitro Diagnostic Market Size Market Share by Type in 2021

Figure 51. Europe Infectious Disease In-vitro Diagnostic Market Size Market Share by Application in 2021

Figure 52. Germany Infectious Disease In-vitro Diagnostic Market Size Growth 2017-2022 ($ Millions)

Figure 53. France Infectious Disease In-vitro Diagnostic Market Size Growth 2017-2022 ($ Millions)

Figure 54. UK Infectious Disease In-vitro Diagnostic Market Size Growth 2017-2022 ($ Millions)

Figure 55. Italy Infectious Disease In-vitro Diagnostic Market Size Growth 2017-2022 ($ Millions)

Figure 56. Russia Infectious Disease In-vitro Diagnostic Market Size Growth 2017-2022 ($ Millions)

Figure 57. Middle East & Africa Infectious Disease In-vitro Diagnostic Market Size Market Share by Region in 2021

Figure 58. Middle East & Africa Infectious Disease In-vitro Diagnostic Market Size Market Share by Type in 2021

Figure 59. Middle East & Africa Infectious Disease In-vitro Diagnostic Market Size Market Share by Application in 2021

Figure 60. Egypt Infectious Disease In-vitro Diagnostic Market Size Growth 2017-2022 ($ Millions)

Figure 61. South Africa Infectious Disease In-vitro Diagnostic Market Size Growth 2017-2022 ($ Millions)

Figure 62. Israel Infectious Disease In-vitro Diagnostic Market Size Growth 2017-2022 ($ Millions)

Figure 63. Turkey Infectious Disease In-vitro Diagnostic Market Size Growth 2017-2022 ($ Millions)

Figure 64. GCC Country Infectious Disease In-vitro Diagnostic Market Size Growth 2017-2022 ($ Millions)

Figure 65. Americas Infectious Disease In-vitro Diagnostic Market Size 2023-2028 ($ Millions)

Figure 66. APAC Infectious Disease In-vitro Diagnostic Market Size 2023-2028 ($ Millions)

Figure 67. Europe Infectious Disease In-vitro Diagnostic Market Size 2023-2028 ($ Millions)

Figure 68. Middle East & Africa Infectious Disease In-vitro Diagnostic Market Size 2023-2028 ($ Millions)

Figure 69. United States Infectious Disease In-vitro Diagnostic Market Size 2023-2028 ($ Millions)

Figure 70. Canada Infectious Disease In-vitro Diagnostic Market Size 2023-2028 ($ Millions)

Figure 71. Mexico Infectious Disease In-vitro Diagnostic Market Size 2023-2028 ($ Millions)

Figure 72. Brazil Infectious Disease In-vitro Diagnostic Market Size 2023-2028 ($ Millions)

Figure 73. China Infectious Disease In-vitro Diagnostic Market Size 2023-2028 ($ Millions)

Figure 74. Japan Infectious Disease In-vitro Diagnostic Market Size 2023-2028 ($ Millions)

Figure 75. Korea Infectious Disease In-vitro Diagnostic Market Size 2023-2028 ($ Millions)

Figure 76. Southeast Asia Infectious Disease In-vitro Diagnostic Market Size 2023-2028 ($ Millions)

Figure 77. India Infectious Disease In-vitro Diagnostic Market Size 2023-2028 ($ Millions)

Figure 78. Australia Infectious Disease In-vitro Diagnostic Market Size 2023-2028 ($ Millions)

Figure 79. Germany Infectious Disease In-vitro Diagnostic Market Size 2023-2028 ($ Millions)

Figure 80. France Infectious Disease In-vitro Diagnostic Market Size 2023-2028 ($ Millions)

Figure 81. UK Infectious Disease In-vitro Diagnostic Market Size 2023-2028 ($ Millions)

Figure 82. Italy Infectious Disease In-vitro Diagnostic Market Size 2023-2028 ($ Millions)

Figure 83. Russia Infectious Disease In-vitro Diagnostic Market Size 2023-2028 ($ Millions)

Figure 84. Spain Infectious Disease In-vitro Diagnostic Market Size 2023-2028 ($ Millions)

Figure 85. Egypt Infectious Disease In-vitro Diagnostic Market Size 2023-2028 ($ Millions)

Figure 86. South Africa Infectious Disease In-vitro Diagnostic Market Size 2023-2028 ($ Millions)

Figure 87. Israel Infectious Disease In-vitro Diagnostic Market Size 2023-2028 ($ Millions)

Figure 88. Turkey Infectious Disease In-vitro Diagnostic Market Size 2023-2028 ($ Millions)

Figure 89. GCC Countries Infectious Disease In-vitro Diagnostic Market Size 2023-2028 ($ Millions)